Evidence map›Paper›PMID 41313533›Full record

ArticleDigestive diseases and sciences2026

Initial Treatment Failure as a Predictor of Proximal Extension in Patients with Newly Diagnosed Limited Ulcerative Colitis: A Retrospective Cohort Study with Propensity Score-Matched Analysis.

Toshiyuki Sato, Jiro Takeuchi, Kazuko Nagase, Tetsuya Shiraishi, Keiko Yokoyama, Soichi Yagi, Koji Kaku, Yasuhiro Takagi, Maiko Ikenouchi, Mikio Kawai and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Toshiyuki SatoDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0001-8307-2445
Jiro TakeuchiInstitute for Clinical and Translational Science, Nara Medical University, Nara, 634-8522, Japan.ORCID http://orcid.org/0000-0002-4904-1693
Kazuko NagaseDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.
Tetsuya ShiraishiDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.
Keiko YokoyamaDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.
Soichi YagiDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0002-2454-2950
Koji KakuDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0003-0988-8897
Yasuhiro TakagiDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0009-0002-8310-9767
Maiko IkenouchiDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0001-5816-5789
Mikio KawaiDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0001-8004-5927
Yoko YokoyamaDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0002-5474-3008
Tetsuya TakagawaDepartment of Data Science, Hyogo Medical University, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0001-7335-6962
Shiro NakamuraSecond Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, 569-8686, Japan.
Hirokazu FukuiDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.ORCID http://orcid.org/0000-0002-8642-5784
Shinichiro ShinzakiDepartment of Gastroenterology, School of Medicine, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan. sh-shinzaki@hyo-med.ac.jp.ORCID http://orcid.org/0000-0002-7051-618X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with ulcerative colitis (UC) frequently experience proximal extension during their disease course.

aimsWe examined whether initial treatment failure affects proximal extension in limited UC.

methodsThis retrospective cohort study comprised patients who were newly diagnosed with limited UC between April 2006 and March 2015. Initial treatment failure was defined as either no remission within 3 months of onset (no remission group) or remission followed by relapse within 3 months (early relapse group). Patients who maintained remission for > 3 months were included in the initial treatment success group. The primary outcome was the incidence of proximal extension. Secondary outcomes included colectomy, hospitalization, and refractoriness to medication. Propensity score matching (PSM) was performed to adjust for baseline differences.

resultsOf 229 eligible patients (median follow-up, 9.6 years), 68 (29.7%) developed proximal extension. Before PSM, initial treatment failure was significantly associated with proximal extension, and this association remained after PSM. In the overall cohort, multivariable Cox analysis confirmed initial treatment failure as an independent risk factor for proximal extension (adjusted hazard ratio 3.2; 95% confidence interval 1.9-5.3). The hospitalization rate was significantly higher in the initial treatment failure group than in the initial treatment success group after PSM.

conclusionInitial treatment failure is an independent prognostic factor for proximal extension in patients with limited UC and is associated with worse long-term outcomes. Careful monitoring and early therapeutic strategies may be warranted for patients with initial treatment failure.

Indexed as

Colitis, UlcerativeAdultColectomyFemaleHospitalizationHumansMaleMiddle AgedPropensity ScoreRecurrenceRemission InductionRetrospective StudiesRisk FactorsTreatment FailureInflammatory bowel diseasePropensity score matchingProximal extensionUlcerative colitis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.